Crystallization (Comment) | Organism |
---|---|
- |
Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
Glu-Val-Asn-Leu-(S)-CH(OH)CH2-Ala-Ala-Glu-Phe | - |
Homo sapiens | |
Glu-Val-Asn-Leu-CONH-Ala-Ala-Glu-Phe | inhibitors based on this structure, molecular size is substantially reduced while maintaining comparable enzyme inhibitory potencies | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
amyloid-beta precursor protein + H2O | Homo sapiens | - |
? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
brain | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
amyloid-beta precursor protein + H2O | - |
Homo sapiens | ? | - |
? | |
amyloid-beta precursor protein + H2O | results in 40-42 residue amyloid-beta peptide | Homo sapiens | ? | - |
? |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0000016 | - |
Glu-Val-Asn-Leu-(S)-CH(OH)CH2-Ala-Ala-Glu-Phe | - |
Homo sapiens | |
0.000036 | - |
Glu-Val-Asn-Leu-CONH-Ala-Ala-Glu-Phe | - |
Homo sapiens |